Bibliographic record

Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes

Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal…. New England Journal of Medicine 2021

Document identifier: CEI-BR-034
Series: Bibliographic record
Version: 1.0
Published: 30 Jul 2026
Last reviewed: 30 Jul 2026
Certainty: Not rated

§1Bibliographic record

§1.1Record

Authors: Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K
Title: Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes
Source: New England Journal of Medicine
Year: 2021
Volume, issue, pages: 385(10):896–907
Digital object identifier: 10.1056/NEJMoa2108269
PubMed identifier: 34215025
Record type: Journal article
Institute identifier: CEI-BR-034

§1.2Institute documents citing this record

No Institute document currently cites this record. It is held in the bibliography because it was retrieved during a search and assessed, and the Institute records what it assessed and did not use as well as what it used.

§1.3Subject tags

efpeglenatide cardiovascular AMPLITUDE-O

Compound Evidence Institute · CEI-BR-034 · https://compoundevidence.com/bibliography/gerstein2021/ · retrieved 30 July 2026